ClinConnect ClinConnect Logo
Search / Trial NCT06698289

Preoperative Sarcopenia and Surgical Outcomes in Colorectal Cancer Patients

Launched by MERSIN UNIVERSITY · Nov 18, 2024

Trial Information

Current as of November 14, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the impact of muscle loss, known as sarcopenia, on the outcomes of surgery for patients with colorectal cancer. Sarcopenia can lead to complications during and after surgery, making recovery more difficult. The researchers want to find out how common sarcopenia is among patients before they have their surgery and how it affects their recovery and overall health after the procedure.

To participate in this study, you need to be at least 18 years old and have a diagnosis of colon cancer. You should also be having surgery at Mersin University General Surgery Department. Participants will be asked to provide information about their health and undergo assessments to evaluate their muscle strength and physical abilities. By joining this study, you’ll help researchers understand how muscle health influences recovery from surgery, potentially improving care for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Having a diagnosis of colon cancer
  • Having undergone surgery at Mersin University General Surgery Department as of 15.11.2024
  • Patients aged 18 years and above
  • Patients whose descriptive and clinical characteristics are recorded in their medical files
  • Those who have signed the Informed Volunteer Consent Form/Written Consent Form
  • Exclusion Criteria:
  • Patients under 18 years of age
  • Patients whose descriptive and clinical characteristics are not recorded in the file records
  • Those who did not sign the Informed Volunteer Form/Written Consent Form

About Mersin University

Mersin University is a distinguished academic institution located in Mersin, Turkey, committed to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, expert faculty, and state-of-the-art facilities to facilitate groundbreaking studies. Mersin University aims to contribute to the global medical community by fostering the development of new therapies and improving patient outcomes through rigorous scientific inquiry and ethical standards in clinical research.

Locations

Mersin, Turkey

Patients applied

0 patients applied

Trial Officials

Mustafa Yılmaz

Principal Investigator

Mersin University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported